• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [21846 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) in combination with capecitabine for HER2-negative locally advanced or metastatic breast cancer - second line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Vedolizumab for ulcerative colitis – second or subsequent line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Palbociclib for advanced or metastatic, oestrogen-receptor positive, HER2-negative, recurrent breast cancer – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Teduglutide (Revestive) - short bowel syndrome: in paediatric patients aged 1-17 years who are dependent on parenteral nutrition
2008     NIHR Horizon Scanning Centre (NIHR HSC) Decitabine (Dacogen) for myelodysplastic syndrome
2011     NIHR Horizon Scanning Centre (NIHR HSC) Exenatide (Byetta) for type 2 diabetes mellitus - in combination with basal insulin
2013     NIHR Horizon Scanning Centre (NIHR HSC) Vedolizumab for Crohn's disease – second or subsequent line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Begelomab (Begesand) - graft versus host disease: acute; steroid resistant – second line
2008     NIHR Horizon Scanning Centre (NIHR HSC) Cladribine (Movectro) for multiple sclerosis; relapsing-remitting
2011     NIHR Horizon Scanning Centre (NIHR HSC) Aganirsen for pathological corneal neovascularisation
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ruxolitinib (Jakavi) for polycythaemia vera – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Caprelsa) for locally advanced or metastatic differentiated thyroid cancer – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Caplacizumab-Thrombotic thrombocytopenic purpura: acquired; acute phase – adjunctive therapy
2008     NIHR Horizon Scanning Centre (NIHR HSC) Capecitabine (Xeloda) in combination with docetaxel for adjuvant therapy in breast cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Idebenone (Catena) for leber's hereditary optic neuropathy - first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for mastocytosis – second or subsequent line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vemurafenib (Zelboraf) for metastatic BRAF V600 mutation positive melanoma in children and adolescents
2016     NIHR Horizon Scanning Centre (NIHR HSC) Relebactam with imipenem and cilastatin - multi-drug resistant or carbapenem resistant Gram-negative infections
2008     NIHR Horizon Scanning Centre (NIHR HSC) Amibegron (SR-58611) for depression
2011     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for visual impairment due to choroidal neovascularisation (CNV) secondary to pathological myopia - first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Monarch™ External Trigeminal Nerve Stimulation (eTNS™) System for depression
2015     NIHR Horizon Scanning Centre (NIHR HSC) GS-6615 for long QT-3 syndrome
2016     NIHR Horizon Scanning Centre (NIHR HSC) Autologous haematopoietic stem cell transplantation - multiple sclerosis: relapsing remitting – second line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Golimumab (CNTO-148) for ankylosing spondylitis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Defibrotide (Defitelio) for hepatic veno-occlusive disease in haematopoietic stem cell transplantation - first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) COGNISION™ for neurological disorders, including dementia
2015     NIHR Horizon Scanning Centre (NIHR HSC) Holoclar for the treatment of limbal stem cell deficiency due to ocular burns
2016     NIHR Horizon Scanning Centre (NIHR HSC) Low dose desmopressin acetate (Noqdirna) - nocturia: idiopathic nocturnal polyuria; symptomatic; in adults – as sole agent or as a combination treatment
2008     NIHR Horizon Scanning Centre (NIHR HSC) ABT-874 for moderate-to-severe chronic plaque psoriasis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Certolizumab pegol (Cimzia) for active ankylosing spondylitis (AS) - second or third line; after intolerance or inadequate response to at least one non-steroidal anti-inflammatory drug (NSAID)
2013     NIHR Horizon Scanning Centre (NIHR HSC) Monarch™ External Trigeminal Nerve Stimulation (eTNS™) System for epilepsy
2015     NIHR Horizon Scanning Centre (NIHR HSC) Midodrine (Bramox) for orthostatic hypotension
2016     NIHR Horizon Scanning Centre (NIHR HSC) Dupilumab - atopic dermatitis: moderate to severe; inadequate response to treatment with topical medications or for whom topical treatments are otherwise medically inadvisable – second line
2008     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat (Zolinza) for cutaneous T-cell lymphoma - second line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (Prolia) for osteoporosis in men
2013     NIHR Horizon Scanning Centre (NIHR HSC) ExAblate® Neuro MR guided focused ultrasound for Parkinson's disease, essential tremor and neuropathic pain
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir alafenamide monotherapy for hepatitis B
2008     NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Laquinimod for multiple sclerosis: relapsing-remitting - first or second line.
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: RhinoChill® intranasal cooling device for protective cooling the brain after a cerebral ischaemic event
2013     NIHR Horizon Scanning Centre (NIHR HSC) NTrainer® for developing non-nutritive sucking in premature and newborn infants
2015     NIHR Horizon Scanning Centre (NIHR HSC) Baricitinib for moderate to severe rheumatoid arthritis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Teriflunomide for relapsing multiple sclerosis (MS) - first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (Xgeva) for recurrent or unresectable giant cell tumour of the bone – first or second line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Inspire® Upper Airway Stimulation System for obstructive sleep apnoea
2015     NIHR Horizon Scanning Centre (NIHR HSC) Certolizumab (Cimzia) for early rheumatoid arthritis – first line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Eculizumab (Soliris) for atypical haemolytic uraemic syndrome - first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab (Herceptin) for HER2 positive early breast cancer – two year regimen
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for psoriatic arthritis – second or subsequent line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Indacaterol/glycopyrronium (QVA-149) for chronic obstructive pulmonary disease
2012     NIHR Horizon Scanning Centre (NIHR HSC) Palifosfamide tromethamine (Zymafos) for advanced soft tissue sarcoma – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Patiromer for hyperkalaemia – first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Emepepimut-S (Stimuvax) for non-small cell lung cancer – maintenance therapy
2015     NIHR Horizon Scanning Centre (NIHR HSC) Alectinib for advanced ALK-positive, non-small cell lung cancer – first line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Xaliproden (Xalprila) for Alzheimer's disease: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) Elacytarabine for relapsed or refractory acute myeloid leukaemia – second or third line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Alectinib for locally advanced or metastatic ALK-positive, non-small cell lung cancer following failure of crizotinib
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tolvaptan for heart failure (NYHA): horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) Axitinib (Inlyta) for advanced and/or metastatic renal cell carcinoma – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Atezolizumab for locally advanced or metastatic non-small cell lung cancer – second line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir disoproxil fumarate for hepatitis B: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) Serelaxin for acute decompensated heart failure – in addition to IV diuretics
2015     NIHR Horizon Scanning Centre (NIHR HSC) Bavituximab for advanced non-small cell lung cancer – second line in combination with docetaxel
2007     NIHR Horizon Scanning Centre (NIHR HSC) Temozolomide (Temodal) for advanced metastatic melanoma: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) H-FABP immunoturbimetric assay with troponin testing for the assessment of heart-related chest pain
2015     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) with erlotinib (Tarceva) for EGFR positive, advanced or metastatic non-small cell lung cancer – first line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tap water home haemodialysis systems for end stage renal failure: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) AIGISRx® antibacterial envelope for preventing infection in implanted cardiac devices
2015     NIHR Horizon Scanning Centre (NIHR HSC) Dabrafenib (Tafinlar) and trametinib (Mekinist) combination therapy for metastatic BRAF V600E positive non-small cell lung cancer
2001     NIHR Horizon Scanning Centre (NIHR HSC) New coronary revascularisation techniques - horizon scanning review
2007     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for hepatocellular carcinoma: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: SoundBite™ hearing system
2015     NIHR Horizon Scanning Centre (NIHR HSC) Daratumumab monotherapy for relapsed and refractory multiple myeloma
2016     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) for diffuse large B-cell lymphoma – maintenance therapy
2001     NIHR Horizon Scanning Centre (NIHR HSC) Imaging in coronary heart disease - horizon scanning review
2002     NIHR Horizon Scanning Centre (NIHR HSC) Adefovir dipivoxil for chronic hepatitis B - horizon scanning review
2007     NIHR Horizon Scanning Centre (NIHR HSC) Serum procalcitonin (PCT) as a marker of bacterial lower respiratory tract infection: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) Femtosecond lasers for cataract surgery
2015     NIHR Horizon Scanning Centre (NIHR HSC) Daratumumab with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma
2016     NIHR Horizon Scanning Centre (NIHR HSC) Dabrafenib (Tafinlar) and trametinib (Mekinist) combination therapy for advanced BRAF mutated non-small cell lung cancer
2001     NIHR Horizon Scanning Centre (NIHR HSC) Anakinra for rheumatoid arthritis - horizon scanning review
2002     NIHR Horizon Scanning Centre (NIHR HSC) Anagrelide for essential thrombocythaemia - horizon scanning review
2007     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Bay 59-7939) for the prevention of venous thromboembolism (VTE) after major orthopaedic surgery: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sensimed triggerfish® for 24-hour monitoring of changes in intraocular pressure in glaucoma
2015     NIHR Horizon Scanning Centre (NIHR HSC) Gemtuzumab ozogamicin (Mylotarg) with conventional chemotherapy for acute myeloid leukaemia – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) ADI-PEG 20 for hepatocellular carcinoma – second line
2001     NIHR Horizon Scanning Centre (NIHR HSC) Memantine for Alzheimer's disease and vascular dementia - horizon scanning review
2002     NIHR Horizon Scanning Centre (NIHR HSC) Aripiprazole for schizophrenia and bipolar disorders - horizon scanning review
2007     NIHR Horizon Scanning Centre (NIHR HSC) Prasugrel for acute coronary artery syndrome with percutaneous coronary intervention: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Argus II™ retinal prosthesis system for peripheral retinal degeneration
2015     NIHR Horizon Scanning Centre (NIHR HSC) MABp1 (Xilonix) for metastatic colorectal cancer –third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Heartcel for heart failure in patients at risk of incomplete revascularisation following coronary artery bypass graft
2001     NIHR Horizon Scanning Centre (NIHR HSC) New products for atopic dermatitis - horizon scanning review
2002     NIHR Horizon Scanning Centre (NIHR HSC) Atrasentan for hormone refractory prostate cancer - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Rubitecan resistant refractory pancreatic cancer - horizon scanning review
2007     NIHR Horizon Scanning Centre (NIHR HSC) Oral topotecan (Hycamtin) for small cell lung cancer: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) Lubiprostone (Amitiza) for chronic idiopathic constipation
2015     NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab (Gazyvaro) for indolent non-Hodgkin lymphoma – first line, in combination with chemotherapy
2016     NIHR Horizon Scanning Centre (NIHR HSC) Furosemide sc2Wear micro-pump patch for oedema in heart failure
2001     NIHR Horizon Scanning Centre (NIHR HSC) Tiotropium for COPD - horizon scanning review